Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Regulation of WNT/β-Catenin Signaling Is Enhanced in Irradiated Medulloblastoma Cells

作者: Swapna Asuthkar , Christopher S. Gondi , Arun Kumar Nalla , Kiran Kumar Velpula , Bharathi Gorantla

DOI: 10.1074/JBC.M112.348888

关键词: CD44BiologyTranscription factorWnt signaling pathwayCell signalingBeta-cateninTransactivationUrokinase receptorCancer researchActivator (genetics)

摘要: Urokinase plasminogen activator receptor (uPAR) is known to promote invasion, migration, and metastasis in cancer cells. In this report, we showed that ionizing radiation (IR)-induced uPAR has a role WNT-β-catenin signaling mediates induction of stem cell (CSC)-like properties medulloblastoma lines UW228 D283. We observed IR induced the expression CSC markers, such as Musashi-1 CD44, activated WNT-7a-β-catenin molecules. Overexpression alone or with treatment led increased WNT-7a-β-catenin-TCF/LEF-mediated transactivation, thereby promoting stemness. contrast, shRNA specific for (pU) suppressed transactivation both vitro vivo. Quercetin, potent WNT/β-catenin inhibitor, uPAR-mediated activation, furthermore, addition recombinant human WNT-7a protein uPAR, indicating existence mutual regulatory relationship between signaling. was physically associated WNT effector molecule β-catenin on membrane, cytoplasm, nucleus IR-treated cells CSC. Most interestingly, demonstrated first time localization transcription factors (TF) their response elements. from uPAR-ChIP, TF protein, protein/DNA array analyses associates activating enhancer-binding 2α (AP2a) gene transcription. Moreover, association β-catenin·TCF/LEF complex various other involved during embryonic development indicates stemness, targeting combination significant therapeutic implications.

参考文章(58)
Nicolai Sidenius, Francesco Blasi, The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer and Metastasis Reviews. ,vol. 22, pp. 205- 222 ,(2003) , 10.1023/A:1023099415940
Herman Dierick, Amy Bejsovec, Cellular mechanisms of wingless/Wnt signal transduction Current Topics in Developmental Biology. ,vol. 43, pp. 153- 190 ,(1999) , 10.1016/S0070-2153(08)60381-6
Kiran Kumar Velpula, Venkata Ramesh Dasari, Andrew J. Tsung, Dzung H. Dinh, Jasti S. Rao, Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 Oncotarget. ,vol. 2, pp. 1028- 1042 ,(2011) , 10.18632/ONCOTARGET.367
S. Killeen, A. Hennessey, Y. El Hassan, B. Waldron, The urokinase plasminogen activator system in cancer: a putative therapeutic target? Drug News & Perspectives. ,vol. 21, pp. 107- ,(2008) , 10.1358/DNP.2008.21.2.1188197
Friedel Nollet, Geert Berx, Francis Molemans, Frans van Roy, Genomic organization of the human beta-catenin gene (CTNNB1). Genomics. ,vol. 32, pp. 413- 424 ,(1996) , 10.1006/GENO.1996.0136
J H de Witte, J A Foekens, N Brünner, J J T M Heuvel, ThH van Tienoven, M P Look, J G M Klijn, A Geurts-Moespot, N Grebenchtchikov, ThJ Benraad, C G J Sweep, Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours British Journal of Cancer. ,vol. 85, pp. 85- 92 ,(2001) , 10.1054/BJOC.2001.1867
Arun Kumar Nalla, Swapna Asuthkar, Praveen Bhoopathi, Meena Gujrati, Dzung H. Dinh, Jasti S. Rao, Suppression of uPAR Retards Radiation-Induced Invasion and Migration Mediated by Integrin β1/FAK Signaling in Medulloblastoma PLoS ONE. ,vol. 5, pp. e13006- ,(2010) , 10.1371/JOURNAL.PONE.0013006
P. Ragno, The urokinase receptor: a ligand or a receptor? Story of a sociable molecule Cellular and Molecular Life Sciences. ,vol. 63, pp. 1028- 1037 ,(2006) , 10.1007/S00018-005-5428-1
Klaus T Preissner, Sandip M Kanse, Andreas E May, Urokinase receptor: a molecular organizer in cellular communication. Current Opinion in Cell Biology. ,vol. 12, pp. 621- 628 ,(2000) , 10.1016/S0955-0674(00)00141-1